Fażi 1/2 Prova Issettjata biex Tittestja ASC618, Terapija tal-Ġeni għall-Emofilja A

Fażi 1/2 Prova Issettjata biex Tittestja ASC618, Terapija tal-Ġeni għall-Emofilja A

Aħbarijiet tal-Emofilja Illum

Image

Please enable the javascript to submit this form

Appoġġjati minn għotjiet edukattivi minn Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, u uniQure, Inc.

SSL essenzjali